|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||205.301 g·mol−1|
|3D model (JSmol)|
Dimethylaminopivalophenone is an opioid analgesic. with a potency ½ that of morphine. It was initially discovered by Russian scientists in 1954 and subsequently rediscovered in the US in 1969. Its LD50 in mice is 83 mg/kg. It has never been marketed commercially, likely due to its low potency and lack of benefits compared to existing agents.
- James H. Brewster; Ernest L. Eliel (2011). "Carbon-Carbon Alkylations with Amines and Ammonium Salts". Organic Reactions. 7 (3): 99–197. doi:10.1002/0471264180.or007.03.
- Edward F. Kleinman (April 2011). Dimethyl(methylene)ammonium Iodide. E-EROS Encyclopedia of Reagents for Organic Synthesis. doi:10.1002/047084289X.rd346. ISBN 978-0471936237.
- Helmut Buschmann; Wolfgang Strassburger; Elmar Friderichs (24 January 2002). "Patent US 20020010178 - 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect". Retrieved 2 October 2015.
- Manmohan S. Atwal; Ludwig Bauer; S. N. Dixit; J. E. Gearien; M. Magahy; R. Morris; C. Pokorny (November 1969). "Analgetics. II. Relationship between structure and activity of some beta-amino ketones". Journal of Medicinal Chemistry. 12 (6): 994–997. doi:10.1021/jm00306a006. PMID 5351480.
- "2,2-dimethyl-3-(dimethylamino)-Propiophenone". ChemIDplus. Retrieved 2 October 2015.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|